136 related articles for article (PubMed ID: 3149185)
1. The effect of an antiprogestin compound (RU486) on gonadotropin and prolactin release in vivo.
Arakawa S; Ohkawa T; Kambegawa A; Okinaga S; Arai K
Asia Oceania J Obstet Gynaecol; 1988 Dec; 14(4):501-7. PubMed ID: 3149185
[TBL] [Abstract][Full Text] [Related]
2. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
3. The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus.
Yanaihara T; Arai K; Kanazawa M; Okinaga S; Yanaihara N; Yanaihara C
Endocrinol Jpn; 1975 Dec; 22(6):525-30. PubMed ID: 782859
[TBL] [Abstract][Full Text] [Related]
4. The in vitro inhibitory action of antiprogestin RU486 on LH and FSH secretion in the absence of progesterone in rats is estrogen-dependent.
Aguilar R; Bellido C; Gonzalez D; Garrido-Gracia JC; Sánchez-Criado JE
Pituitary; 2000 Nov; 3(3):153-8. PubMed ID: 11383479
[TBL] [Abstract][Full Text] [Related]
5. Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat.
Sánchez-Criado JE; Martín De Las Mulas J; Bellido C; Tena-Sempere M; Aguilar R; Blanco A
Neuroendocrinology; 2004; 79(5):247-58. PubMed ID: 15205556
[TBL] [Abstract][Full Text] [Related]
6. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
7. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
9. Anterior pituitary sensitivity in immature female rats stimulated with gonadotrophin releasing hormone in vivo: effect of priming with oestrogen, pregnant mare serum gonadotrophin or brain lesion.
De Ziegler D; Wilkinson M; Cassard D; Ruf KB
J Endocrinol; 1977 Jul; 74(1):99-109. PubMed ID: 327011
[TBL] [Abstract][Full Text] [Related]
10. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
11. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
12. Relationships among LH, FSH and prolactin secretion, storage and response to secretagogue and hypothalamic GnRH content in ovariectomized pony mares administered testosterone, dihydrotestosterone, estradiol, progesterone, dexamethasone or follicular fluid.
Thompson DL; Garza F; St George RL; Rabb MH; Barry BE; French DD
Domest Anim Endocrinol; 1991 Apr; 8(2):189-99. PubMed ID: 1906388
[TBL] [Abstract][Full Text] [Related]
13. Hypersecretion of follicle-stimulating hormone (FSH) on estrous afternoon in rats treated with RU486 in proestrus.
Tébar M; Ruiz A; Sánchez-Criado JE
Cell Mol Neurobiol; 1996 Jun; 16(3):421-6. PubMed ID: 8818408
[TBL] [Abstract][Full Text] [Related]
14. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
Permezel JM; Lenton EA; Roberts I; Cooke ID
J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
[TBL] [Abstract][Full Text] [Related]
16. Antiprogestins RU486 and ZK299 suppress basal and LHRH-stimulated FSH and LH secretion at pituitary level in the rat in an oestrous cycle stage-dependent manner.
Bellido C; Gonzalez D; Aguilar R; Sánchez-Criado JE
J Endocrinol; 1999 Oct; 163(1):79-85. PubMed ID: 10798914
[TBL] [Abstract][Full Text] [Related]
17. Some aspects on pituitary function in human and rat anovulatory cycles.
Makino T; Shiina M; Ohno T; Iizuka R; Tamaoki B
Endocrinol Jpn; 1976 Dec; 23(6):445-9. PubMed ID: 798684
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive potential of RU 486 by ovulation inhibition: II. Suppression of pituitary gonadotropin secretion in vitro.
Wolf JP; Danforth DR; Ulmann A; Baulieu EE; Hodgen GD
Contraception; 1989 Aug; 40(2):185-93. PubMed ID: 2503297
[TBL] [Abstract][Full Text] [Related]
19. Interaction between ovarian and adrenal steroids in the regulation of gonadotropin secretion.
Mahesh VB; Brann DW
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):495-513. PubMed ID: 1562521
[TBL] [Abstract][Full Text] [Related]
20. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
